Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Dry eye, Eye inflammation, Eye swelling, Neck pain
Clinical narrative: Ophthalmology has diagnosed uveitis; On 02Apr I suffered partial vision loss; inflammation of left eye blood vessels; Approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved.  About 3 weeks later, noticed swelling and dry, tightness in my left eye.  This lasted several days.; Approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved.  About 3 weeks later, noticed swelling and dry, tightness in my left eye.  This lasted several days.; Approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved.  About 3 weeks later, noticed swelling and dry, tightness in my left eye.  This lasted several days.; Approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved.  About 3 weeks later, noticed swelling and dry, tightness in my left eye.  This lasted several days.; This is a spontaneous report from a contactable Other Health care Professional (Patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL3246, Expiration Date: not reported) via an unspecified route of administration in left arm on 03Feb2021 09:30 as dose 2, single for COVID-19 immunization. Medical history included hypertension, lung disorder, allergy to sting nitrofurans, bee stings, simvastatin. Concomitant medication(s) (within 2 weeks of vaccination) included losartan; pravastatin; glucosamine; amlodipine. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL3246, Expiration Date: not reported) via an unspecified route of administration in left arm on 13Jan2021 14:00 as dose 1, single for COVID-19 immunization. Approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved.  About 3 weeks later, noticed swelling and dry, tightness in my left eye.  This lasted several days.  On 02Apr2021, patient suffered partial vision loss.  Ophthalmology has diagnosed uveitis, inflammation of left eye blood vessels.  This was ongoing. Events resulted in doctor or other healthcare professional office/clinic visit , Emergency room/department or urgent care. The patient received treatment as a result of the events with currently prescribed medications. The patient underwent lab tests and procedures which included sars-cov-2 test negative: negative on 02Apr2021.The outcome of the events ophthalmology has diagnosed uveitis, suffered partial vision loss and inflammation of left eye blood vessels was not recovered, approx 1 hr after 2nd vax, tight pain in left side of neck, that promptly resolved. about 3 weeks later, noticed swelling and dry, tightness in my left eye. this lasted several days was recovered.  Information on Lot/Batch number was available. Additional information has been requested.; Sender's Comments: Considering a plausible temporal relationship, a possible contributory role of suspect product BNT162B2 to the reported Uveitis and vision loss cannot be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.